Analysis of data with imbalance in the baseline outcome variable for randomized clinical trials

被引:32
|
作者
Wei, L [1 ]
Zhang, J [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
来源
DRUG INFORMATION JOURNAL | 2001年 / 35卷 / 04期
关键词
clinical trial; baseline imbalance; analysis of covariance; efficiency; conditional property;
D O I
10.1177/009286150103500417
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In randomized clinical trials, substantial imbalance in the baseline outcome variable may occur by chance. Inference on treatment effect may be confounded by such imbalance if not properly accounted for The usual unadjusted analysis may be conditionally biased with an inflated Type I error rate or reduced power conditioning on the baseline imbalance in the observed sample. This paper reviews methods for baseline, adjustment with emphasis on the analysis of co-variance (ANCOVA) model with the baseline outcome as a covariate. Many issues on the ANCOVA model, including the nature of the adjustment, unconditional and conditional properties of treatment effect estimate fi-om the ANCOVA, and baseline with measurement errors are discussed. In summary, the ANCOVA model with the baseline outcome as a covariate is more efficient unconditionally, and has better statistical properties conditionally, than the usual analysis of variance (ANOVA) analysis based on either posttreatment outcome or change from baseline and, therefore, is recommended. A real-life data set is analyzed and used to illustrate the unconditional and conditional properties.
引用
下载
收藏
页码:1201 / 1214
页数:14
相关论文
共 50 条
  • [31] Dealing with missing outcome data in meta-analysis of clinical trials
    Higgins, JPT
    White, IR
    Wood, AM
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 88S - 88S
  • [32] Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Reply
    Liu, G. F.
    Lu, K.
    Mogg, R.
    Mallick, M.
    Mehrotra, D. V.
    STATISTICS IN MEDICINE, 2010, 29 (13) : 1457 - 1457
  • [33] Baseline Matters: The Importance of Covariation for Baseline Severity in the Analysis of Clinical Trials
    Nunes, Edward V.
    Pavlicova, Martina
    Hu, Mei-Chen
    Campbell, Aimee N.
    Miele, Gloria
    Hien, Denise
    Klein, Donald F.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2011, 37 (05): : 446 - 452
  • [34] Specification of covariance structure in longitudinal data analysis for randomized clinical trials
    Lu, Kaifeng
    Mehrotra, Devan V.
    STATISTICS IN MEDICINE, 2010, 29 (04) : 474 - 488
  • [35] Analysis of an incomplete binary outcome dichotomized from an underlying continuous variable in clinical trials
    Ma, Chenchen
    Shen, Xin
    Qu, Yongming
    Du, Yu
    PHARMACEUTICAL STATISTICS, 2022, 21 (05) : 907 - 918
  • [36] Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis
    Friede, Tim
    Kieser, Meinhard
    PHARMACEUTICAL STATISTICS, 2011, 10 (01) : 8 - 13
  • [37] Baseline imbalance and heterogeneity are present in meta-analyses of randomized clinical trials examining the effects of exercise and medicines for blood pressure management
    Wewege, Michael A.
    Hansford, Harrison J.
    Shah, Brishna
    Gilanyi, Yannick L.
    Douglas, Susan R. G.
    Parmenter, Belinda J.
    McAuley, James H.
    Jones, Matthew D.
    HYPERTENSION RESEARCH, 2022, 45 (10) : 1643 - 1652
  • [38] Baseline imbalance and heterogeneity are present in meta-analyses of randomized clinical trials examining the effects of exercise and medicines for blood pressure management
    Michael A. Wewege
    Harrison J. Hansford
    Brishna Shah
    Yannick L. Gilanyi
    Susan R. G. Douglas
    Belinda J. Parmenter
    James H. McAuley
    Matthew D. Jones
    Hypertension Research, 2022, 45 : 1643 - 1652
  • [39] Cost-effectiveness as an outcome in randomized clinical trials
    Hlatky, Mark A.
    Owens, Douglas K.
    Sanders, Gillian D.
    CLINICAL TRIALS, 2006, 3 (06) : 543 - 551
  • [40] Outcome of hyperfractionated radiation therapy in randomized clinical trials
    Willers, H.
    Liertz-Petersen, C.
    Dubben, H.-H.
    Beck-Bornholdt, H.-P.
    International Journal of Radiation Oncology, Biology, Physics, 1998, 40 (01):